Thomas A Fitzgerald - Net Worth and Insider Trading
Thomas A Fitzgerald Net Worth
The estimated net worth of Thomas A Fitzgerald is at least $1,394 dollars as of 2024-06-23. Thomas A Fitzgerald is the CFO of TransCode Therapeutics Inc and owns about 1,408 shares of TransCode Therapeutics Inc (RNAZ) stock worth over $1,394. Details can be seen in Thomas A Fitzgerald's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas A Fitzgerald has not made any transactions after 2023-09-28 and currently still holds the listed stock(s).
Transaction Summary of Thomas A Fitzgerald
Thomas A Fitzgerald Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas A Fitzgerald owns 1 companies in total, including TransCode Therapeutics Inc (RNAZ) .
Click here to see the complete history of Thomas A Fitzgerald’s form 4 insider trades.
Insider Ownership Summary of Thomas A Fitzgerald
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAZ | TransCode Therapeutics Inc | 2023-09-28 | director & VP & Chief Financial Officer |
Thomas A Fitzgerald Latest Holdings Summary
Thomas A Fitzgerald currently owns a total of 1 stock. Thomas A Fitzgerald owns 1,408 shares of TransCode Therapeutics Inc (RNAZ) as of September 28, 2023, with a value of $1,394.
Latest Holdings of Thomas A Fitzgerald
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RNAZ | TransCode Therapeutics Inc | 2023-09-28 | 1,408 | 0.99 | 1,394 |
Holding Weightings of Thomas A Fitzgerald
Thomas A Fitzgerald Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas A Fitzgerald has made a total of 1 transactions in TransCode Therapeutics Inc (RNAZ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TransCode Therapeutics Inc is the acquisition of 1,234 shares on September 28, 2023, which cost Thomas A Fitzgerald around $25,169.
Insider Trading History of Thomas A Fitzgerald
- 1
Thomas A Fitzgerald Trading Performance
GuruFocus tracks the stock performance after each of Thomas A Fitzgerald's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas A Fitzgerald is -70.26%. GuruFocus also compares Thomas A Fitzgerald's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas A Fitzgerald within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas A Fitzgerald's insider trading performs compared to the benchmark.
Performance of Thomas A Fitzgerald
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -43.32 |  | | | | |
| Relative Return to S&P 500(%) | -39.08 | | | | | |
Thomas A Fitzgerald Ownership Network
Thomas A Fitzgerald Owned Company Details
What does TransCode Therapeutics Inc do?
Who are the key executives at TransCode Therapeutics Inc?
Thomas A Fitzgerald is the director & VP & Chief Financial Officer of TransCode Therapeutics Inc. Other key executives at TransCode Therapeutics Inc include director & 10 percent owner & Chief Executive Officer Robert Michael Dudley , 10 percent owner Anna Moore , and 10 percent owner Zdravka Medarova .
TransCode Therapeutics Inc (RNAZ) Insider Trades Summary
Over the past 18 months, Thomas A Fitzgerald made 1 insider transaction in TransCode Therapeutics Inc (RNAZ) with a net purchase of 49,350. Other recent insider transactions involving TransCode Therapeutics Inc (RNAZ) include a net purchase of 154,607 shares made by Robert Michael Dudley ,
In summary, during the past 3 months, insiders sold 0 shares of TransCode Therapeutics Inc (RNAZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TransCode Therapeutics Inc (RNAZ) were sold and 5,099 shares were bought by its insiders, resulting in a net purchase of 5,099 shares.
TransCode Therapeutics Inc (RNAZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
TransCode Therapeutics Inc Insider Transactions
Thomas A Fitzgerald Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas A Fitzgerald. You might contact Thomas A Fitzgerald via mailing address: C/o Transcode Therapeutics, Inc., 6 Liberty Square, #2382, Boston Ma 02109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
